We evaluated a novel three-dimensional primary culture system using micro-space plates to determine the expression levels of 61 target (drug-metabolizing enzymes, transporters, and nuclear receptors) mRNAs in human hepatocytes. We measured mRNA expression levels of many target genes in four lots of cryopreserved human hepatocyte primary cells after 120 h of culture and compared differences in mRNA expression levels between cultures using traditional plates and those using micro-space plates. In this study, we show that the mRNA levels of many experimental targets in human hepatocytes before inoculation resemble the levels inside the human liver. Furthermore, we show that the rate of change of expression levels of many target mRNAs relative to the value before inoculation of the hepatocytes into micro-space plates was relatively smaller than the rate of change in hepatocytes inoculated into traditional plates. Pharmacokinetics-related examinations using this system are possible within a time frame of 120 h. We report that this novel three-dimensional culture system reproduces mRNA expression levels that are nearer to those in the liver in vivo and is an excellent platform for maintaining mRNA expression levels of drug-metabolizing enzymes and transporters when compared to common monolayer cultures.
Introduction
When hepatocytes are cultured in a monolayer, the cells form a flat pavement-like shape, and as a result, many liver functions such as albumin secretion and drug metabolism are lost. To overcome this problem, Landry et al. 1¥ and Tong et al. 2¥ attempted a three-dimensional culture method that allows spheroid formation so as to achieve a state that is nearer to that found in the liver in vivo. Cultivation of hepatocytes using Matrigel results in the well-known promoting effects of conglobation, condensation object formation, and polarization of the hepatocytes. 3¥ Moreover, collagen sandwich culture systems, consisting of collagen gel cultivated on both sides of the hepatocytes, enable bile duct formation and drug metabolism to function over a longer period of time. 4¥ Furthermore, the three-dimensional culture system in which the hollow interior of fibers is filled with hepatocytes is known to support albumin and ammonia metabolism, for example, for a long period of time. 5¥ However, these three-dimensional cultures are inferior in operative convenience or observational capacity when compared with common monolayer culture methods that use traditional plates, although three-dimensional cultures are excellent for achieving highly maintainable cell functions. Yakemoto et al. 6¥ developed a novel three-dimensional culture system using micro-space plates that is equivalent to a monolayer culture system in terms operational and observational convenience. In this system, cells in human primary hepatocyte cultures grown on micro-space plates were reported to begin conglobulating and forming spheroids from day 3 ¤72 h¥ of culture, and spheroids are present in almost all micro-vessels on day 5 ¤120 h¥.
6, 7¥ We also reported comparable results. 8¥ Drug-metabolizing enzymes play a central role in the metabolism, elimination, and detoxification of xenobiotics and drugs that are introduced into the human body. 9¥ Transporters play a vital role in the absorption, distribution, and excretion processes that influence the pharmacodynamics and pharmacokinetics of drugs. Nuclear receptors are known to be important transcription factors that regulate widely diverse physiological functions such as the control of cell differentiation and homeostasis, as well as the expression of enzymes and transporters. We have confirmed the mRNA expression levels of many of these experimental targets in the liver.
10®14¥ Furthermore, we have been studying the changes in mRNA levels to determine initial levels of various drug-metabolizing enzymes and transporters in primary monolayer cultures of hepatocytes using traditional plates.
15®17¥ However, little information is available on mRNA expression profiles of drug-metabolizing enzymes, transporters, and receptors in novel three-dimensional primary human hepatocyte culture systems using microspace plates. Hence, we set out to examine mRNA expression levels of drug-metabolizing enzymes, transporters, and nuclear receptors in these novel systems, paying particular attention to pharmacokinetics-related genes.
In the present study, we measured the expression levels of 61 target mRNAs in the primary culture of cryopreserved human hepatocytes and we determined differences in mRNA levels between cultures on traditional plates and on microspace plates.
Materials and Methods
Materials: Cryopreserved human hepatocytes ¤donor #1 ªLot 100«, donor #2 ªLot LMP«, donor #3 ªLot ONQ«, and donor #4 ªLot VUA«¥ ¤Table 1¥ were purchased from In Vitro Technologies, Inc. ¤Baltimore, MD, USA¥. Further, total RNA was prepared from human livers. These livers were supplied by the National Disease Research Interchange ¤NDRI¥ in the USA, and were obtained by us from the NonProfit Organization Human & Animal Bridging Research Institute ¤HAB¥ ¤Chiba, Japan¥. Informed consent to use these tissues for research purposes was obtained from all donors. The total RNA source information for these human tissues is shown in Table 1 . The present study was approved by the Ethics Committee of Otsuka Pharmaceutical Factory, Inc.
Trypan blue was obtained from Merck ¤Darmstadt, Germany¥; hepatocyte culture medium ¤CC-3198¥ was from Lonza ¤Walkersville, MD, USA¥; RNeasy Mini Kit and QIAshredder were from Qiagen ¤Hilden, Germany¥; yeast tRNA was from Life Technologies, Inc. ¤Rockville, MD, USA¥; and TaqMan One-Step RT-PCR Master Mix Reagents were from Applied Biosystems ¤Foster City, CA, USA¥. All other chemicals used in this study were of reagent grade.
Primary culture of human hepatocytes: Primary culture of cryopreserved human hepatocytes was carried out according to the method of Nishimura et al. 18¥ Cell suspensions with viability rates of 84 to 94%, as assessed by trypan blue dye exclusion, were used for the experiments ¤Table 1¥. Cell suspensions were diluted to a final concentration of 2.5 ' 10 5 viable cells/mL using hepatocyte culture medium, and inocula of 1 ' 10 5 viable cells/ 0.4 mL/well were introduced into 24-well plates. Culture plates ¤24 wells¥ included type I collagen-coated traditional plates ¤AGC Techno Glass Co., Ltd., Chiba, Japan¥ and special glass-coated micro-space plates ¤Kuraray Co., Ltd., Tokyo, Japan¥. A micro-space plate has an array of 200 µm ' 200 µm ' 50 µm compartments on the plate surface. The hepatocytes were used for measurement of lactate dehydrogenase ¤LDH¥ activities or mRNA levels 120 h after inoculation.
Measurement of intracellular LDH activity: The hepatocytes were washed twice with 1 mL of ice-cold phosphate-buffered saline ¤%¥ and dissolved by adding 0.4 mL of 0.1% Triton X-100. The samples ¤the hepatocytes dissolved with Triton X-100¥ were analyzed for LDH using an autoanalyzer ¤Model 7170, Hitachi Co., Tokyo, Japan¥. LDH activities were measured by the Japan Society of Clinical Chemistry ¤JSCC¥ transferable method using L type WAKO LDH J ¤Wako Pure Chemicals, Osaka, Japan¥. The total amount of RNA was the same as that used for the measurement of mRNA expression levels in our previous studies.
Preparation of total RNA: Total RNA was extracted from hepatocytes using the QIAshredder and RNeasy mini kit.
Oligonucleotides: The pairs of primers and the TaqMan probes for the target mRNAs were designed based on the human mRNA sequence using Primer Express software ¤Applied Biosystems¥. The pair of primers and the TaqMan probe for aryl hydrocarbon receptor ¤AHR¥ ¤GenBank accession number NMð001621¥ and aryl hydrocarbon receptor nuclear translocator ¤ARNT¥ ¤GenBank accession number NMð001668¥ used in the RT-PCR are as follows: AHR forward primer: 5$-GGTTGTGATGC-CAAAGGAAG-3$ ¤position from the initiation codon: 895®914¥, reverse primer: 5$-ATCATTCGGATATGG-GACTCG-3$ ¤position from the initiation codon: 1022® 1002¥, probe: 5$-AGCTGTGCACGAGAGGCTCAGGT-TATCA-3$ ¤position from the initiation codon: 941® 968¥; ARNT forward primer: 5$-ATGGTACCCACCTG-TAGTGCC-3$ ¤position from the initiation codon: 343® 363¥, reverse primer: 5$-CCGCAAGGACTTCATGTGAG-3$ ¤position from the initiation codon: 429®410¥, probe: 5$-CAGACAAGCTAACCATCTTACGCATGGC-3$ ¤posi-tion from the initiation codon: 377®404¥. Each primer and/or probe was homology searched using NCBI BLAST to ensure that it was specific for the target mRNA transcript. The pairs of forward and reverse primers and the TaqMan probes, except for the targets used for RT-PCR analysis, employed sequences that have been reported elsewhere.
11,13,15,18®22¥ QIAGEN Japan ¤Tokyo, Japan¥ synthesized the primers and Genosys Division of SIGMA-ALDRICH JAPAN K.K. ¤Ishikari, Hokkaido, Japan¥ provided the TaqMan probes. TaqMan probes contained 6-carboxyfluorescein ¤FAM¥ at the 5$-end and 6-carboxytetramethyl-rhodamine ¤TAMRA¥ at the 3$-end, and were designed to hybridize to sequences located between the PCR primers.
TaqMan RT-PCR conditions: Total RNA samples obtained from adult human livers were diluted to 10 µg/mL with RNase-free water containing 50 µg/mL yeast tRNA. Total RNA at 30 ng per 20 µL of reaction mixture was used for measurement of the target mRNA in each tissue sample. Total RNA samples obtained from hepatocytes were diluted to about 4 µg/mL with 50 µg/mL yeast tRNA. Total RNA at about 12 ng per 20 µL of reaction mixture was used for measurement of the target mRNA in each sample. For RT-PCR, the TaqMan One-Step RT-PCR Master Mix Reagents Kit ¤Applied Biosystems¥, containing 300 nM forward primer, 900 nM reverse primer, and 200 nM TaqMan probe, was used at 20 µL/tube. RT-PCR assay was performed using the Applied Biosystems 7500 Fast RealTime PCR System with the following profile: 1 cycle at 48ôC for 30 min, 1 cycle at 95ôC for 10 min, and 40 cycles at 95ôC for 15 s and 60ôC for 1 min. The threshold cycle ¤Ct¥ was calculated by the instrumentös software ¤7500 Fast System ver. 1.3.1¥. Figure 1 were performed in duplicate, and the mean values were calculated. In particular, the data are shown as the mean + SD for hepatocytes from four humans. Statistical analysis was performed using Studentös t test. Significance was set at p g 0.05.
Statistical analysis: Experiments with hepatocyte cultures shown in
Relative expression of each mRNA was calculated using the ¼Ct method ªwhere ¼Ct is the value obtained by subtracting the Ct value of hypoxanthine phosphoribosyltransferase 1 ¤HPRT1¥ mRNA from the Ct value of the target mRNA«, as employed in previous studies.
15,23¥
Specifically, the amount of target mRNA relative to HPRT1 mRNA is expressed as 2 ®¤¼Ct¥ . Data are expressed as the ratio of target mRNA to HPRT1 mRNA. The Ct value of each target of the hepatocytes and liver samples shown in Table 2 was measured in duplicate, and the mean values were calculated. Furthermore, the data in 
Results
In the present study, the level of intracellular LDH activity, which is a biomarker for the cell number, was comparable in both the traditional plate and the micro-space plate cultures at 120 h after inoculation ¤Fig. 1¥. Since HPRT1 mRNA exhibited stable expression under various conditions, 24,25¥ it was chosen as the endogenous control for the measurement of target mRNAs. The expression of 61 target mRNAs ¤drug-metabolizing enzymes, transporters, and nuclear receptors¥ were measured in the ten samples of human liver and the four lots of cryopreserved human hepatocytes, and mRNA expression levels were compared between the livers and hepatocytes ¤Table 2¥. These data show that the mRNA levels of many targets in the human hepatocytes before inoculation resemble the levels inside the human liver.
The expression of these 61 target mRNAs in primary cultures of the four lots of cryopreserved human hepatocytes after 120 h of culture was measured, and mRNA expression levels of the cultures in traditional plates and in micro-space plates were compared ¤Figs. 2®6¥. Expression levels of CYP1A1 and CYP51 mRNA in the hepatocyte cultures in both plates increased above initial levels. In contrast, the expression levels of CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP2J2, CYP3A4, CYP4A11, CYP4F2, CYP4F3, CYP7B1, CYP8B1, and CYP27 mRNA in the hepatocyte cultures in both plates decreased to below the initial levels. There was no difference in the expression levels of CYP2C19 and CYP3A5 mRNA between the hepatocytes before inoculation or after growth in both types of plates. Furthermore, the expression levels of all CYP mRNAs cultured in micro-space plates were either higher than or nearly equal to those in traditional plates ¤Fig. 2¥.
The expression levels of UGT1A6 and UGT1A9 mRNA in the hepatocyte cultures in both plates after 120 h of culture increased to well above the initial levels. Moreover, the expression levels of all SULT and UGT mRNAs in the hepatocyte cultures from micro-space plates were higher than or nearly equal to those in traditional plates ¤Fig. 3¥. The expression levels of ABCC1, ABCC2, ABCC5, and ABCG2 mRNA in the hepatocyte cultures in both plates after 120 h of culture had increased above initial levels, while mRNA expression levels of these ABC transporters in the micro-space plate hepatocyte cultures were nearly equal to or lower than those in traditional plates ¤Fig. 4¥. On the other hand, the expression levels of ABCB4, ABCB11, ABCC3, and ABCC6 mRNA in the hepatocyte cultures in both plates decreased to below initial levels. In addition, mRNA expression levels of these ABC transporters in the hepatocyte cultures in micro-space plates were higher than or nearly equal to those in traditional plates. There was no difference in the expression levels of ABCB1 mRNA between the hepatocytes before inoculation or after 120 h of culture in both plates ¤Fig. 4¥.
The expression levels of SLCO1A2 ¤SLC21A3¥ mRNA in the hepatocyte cultures in micro-space plates increased above the initial levels after 120 h of culture ¤Fig. 5¥. In addition, the expression of SLC22A5 mRNA in the hepatocyte cultures in both plates increased above initial levels, but expression in the micro-space plates was lower than in the traditional plates. However, the expression levels of SLC10A1, SLCO1B1 ¤SLC21A6¥, SLCO2B1 ¤SLC21A9¥, SLC22A1, SLC22A7, and SLC22A9 mRNA in the hepatocyte cultures in micro-space plates were higher than or nearly equal to those in traditional plates. There was no difference in the expression levels of SLC22A3 mRNA between the hepatocytes before inoculation or after 120 h of culture in both plates ¤Fig. 5¥. The dotted line indicates the value before inoculation, which was assigned a value of 1. Open ( , , , ) and closed ( , , , ) symbols represent the individual data obtained from cultures grown in traditional plates and micro-space plates, respectively. Circles ( , ), triangles ( , ), squares ( , ) and diamonds ( , ) indicate the individual data of Lot 100, LMP, ONQ and VUA, respectively. Significant differences between the two types of plates were observed for CYP1A2, CYP2D6, CYP4A11, CYP7B1, CYP8B1, and CYP27 only (p < 0.05).
Relative ratio to value before inoculation The expression levels of NR1C3 mRNA in the hepatocyte cultures in both plates increased above initial levels. The expression levels of NR1I3 mRNA in the hepatocyte cultures in both plates decreased below initial levels, but its expression in the hepatocyte cultures in micro-space plates was higher than in traditional plates. No difference was observed in the mRNA expression levels of other nuclear receptors between the hepatocytes before inoculation or after 120 h of culture in both plates ¤Fig. 6¥.
Discussion
It has been reported that in novel three-dimensional primary culture systems, cells develop spheroid-like forms after day 5 ¤120 h¥ of culture.
6®8¥ In addition, we reported that the secretion of albumin in this culture system is stable after 96 h of culture. 8¥ Bowen et al. also reported the mRNA induction of CYPs such as CYP1A1 and CYP3A4 following drug exposure for 5 days ¤120 h¥ in human hepatocyte monolayer cultures using traditional plates. 26¥ In the present study, we compared the expression profiles of 61 target ¤drug-metabolizing enzymes, transporters, AHR, ARNT, and nuclear receptors¥ mRNAs in human hepatocytes after 120 h of culture in a common monolayer culture system using traditional plates and in a novel three-dimensional primary culture system using micro-space plates.
We found that the fluctuating mRNA expression range of metabolic enzymes and transporters in human hepatocytes cultured in the novel three-dimensional system was lower than or nearly equal to that observed in hepatocytes cultured in common monolayer plates ¤Figs. 2®5¥. Furthermore, we reported previously that the secretion of albumin in the three-dimensional cultures is well maintained compared with common monolayer cultures. 8¥ Therefore, it appears that human hepatocytes grown in novel three-dimensional primary cultures achieve a state nearer to that of the human liver in vivo compared to traditional monolayer culture.
Many researchers 26®31¥ use traditional plates to evaluate the induction of various drug-metabolizing enzymes and transporters in primary monolayer cultures of human hepatocytes. We have also used primary monolayer cultures of human hepatocytes in preclinical drug development to evaluate candidates for the induction of drug-metabolizing enzymes in humans. 32®34¥ However, this system is known to cause increased or decreased expression levels of many drug-metabolizing enzymes and transporters as cultivation time increases.
15®17,26¥ Landry et al. 1¥ and Tong et al. 2¥ used a three-dimensional culture system to induce spheroid formation. This cultivation system, however, is complicated to operate and is unsuitable for drug development screening. In contrast, our novel three-dimensional cultures are superior to traditional monolayer culture systems in maintaining mRNA expression levels of drug-metabolizing enzymes and transporters and in terms of operation and ease of observation. Furthermore, the mRNA expression of drugmetabolizing enzymes CYP1A2 and CYP3A4 after exposure to inducers was higher in our novel three-dimensional cultures than in traditional monolayer cultures.
8¥
The adenovirus vector system is used to introduce a target gene into various types of cells, particularly liver-derived cells, with high efficiency.
35,36¥ Aoyama et al. 37¥ developed an adenovirus-mediated system using HepG2 cells for expression of multiple CYPs at desired ratios. Their system will be useful for assessing the contributions of different enzymes such as CYP3A4 and CYP2C19 to the metabolic conversion of drug candidates. However, it is difficult to reproduce the metabolism and transportation profiles of drug candidates in the liver, where the levels of many drug-metabolizing enzymes, drug transporters, and nuclear receptors are constantly changing. Nonetheless, we have simultaneously measured the mRNA expression levels of drug-metabolizing enzymes, transporters, and nuclear receptors in the present study, thereby demonstrating that our method can evaluate many pharmacokinetics-related genes simultaneously within a relatively short time ¤120 h¥. Therefore, our system produces conditions that more closely resemble those found in the liver in vivo, and thus may be a better technique for the simultaneous evaluation of the metabolic and transportation abilities of human hepatocytes when challenged with drug candidates or biogenic substances. Furthermore, our method does not use genetically modified cell lines; therefore, time-consuming and complicated issues regarding the ethics of using transgenics are circumvented.
In conclusion, the expression profiles of 61 target ¤drug-metabolizing enzymes, transporters, and nuclear receptors¥ mRNAs in human hepatocyte cultures were compared between cultures grown in traditional plates and in microspace plates. The results indicate that the novel threedimensional culture system is superior to the traditional system in maintaining mRNA expression of drug-metabolizing enzymes and transporters. This in vitro three-dimensional culture system may be useful for evaluating the pharmacokinetics, pharmacodynamics, and toxicity of drug candidates and biogenic substances.
